Genome Sequence of SCB34, a Sequence Type 131 Multidrug-Resistant Escherichia coli Isolate Causing Neonatal Early-Onset Sepsis

Susana Chavez-Bueno; Michael W Day; Inimary T Toby; Darrin R Akins; David W Dyer

doi:10.1128/genomeA.00514-14

Genome Sequence of SCB34, a Sequence Type 131 Multidrug-Resistant Escherichia coli Isolate Causing Neonatal Early-Onset Sepsis

Genome Announc. 2014 Jun 12;2(3):e00514-14. doi: 10.1128/genomeA.00514-14.

Authors

Susana Chavez-Bueno¹, Michael W Day², Inimary T Toby², Darrin R Akins², David W Dyer²

Affiliations

¹ Department of Pediatrics, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma, USA susana-chavez-bueno@ouhsc.edu.
² Department of Microbiology and Immunology, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma, USA.

Abstract

SCB34 is a sequence type 131, highly invasive, multidrug-resistant Escherichia coli isolate that produced neonatal bacteremia. Whole-genome sequencing was performed using a 250-bp library on the Illumina MiSeq platform; 5,910,264 reads were assembled de novo using the A5 assembly pipeline. The total contig length was 5,227,742 bp; the RAST server was used for annotation.

Grants and funding

P20 GM103447/GM/NIGMS NIH HHS/United States